ALYREF and ovarian carcinoma: We found that ALYREF was amplified in multiple cancers including ovarian cancer, and gene amplification was correlated with ALYREF expression, whereas DNA methylation was not significantly associated with ALYREF expression in ovarian cancer (Figs. 8A–C and EV8A,B).